Home » Newsletters » BioWorld Science

BioWorld Science

July 9, 2004

View Archived Issues

Nycomed terminates Oxygent license agreement

FDA approves new dosing options for Prevacid SoluTab

Chiron acquires Sagres Discovery

trans-ISA-247 completes single ascending dose study

End-of-phase II meeting held for HspE7

Icatibant awarded orphan drug status for edema in severe burn patients

U.S. phase I trial of Exherin cleared to begin

New oxymorphone ER trial protocol agreed under SPA

GOG submits IND for Xyotax study in ovarian cancer

DOV reaches agreement with FDA on clinical trial program for DOV diltiazem

Abbott and Celera form cancer therapeutics collaboration

Acusphere and Nycomed in European partnership for AI-700

MeNZB meningococcal B vaccine approved in New Zealand

Procter & Gamble license Geron's hTERT technology for research

Enrollment open in phase II Xolair peanut allergy study

Phase III study shows benefit of Bonviva/Boniva injection at extended intervals

Nebido completes European mutual recognition procedure

Histamine H3 receptor modulators claimed by Kyowa Hakko

Sponge-derived terpenoids reported by Galileo Laboratories

Tyrosine kinase inhibitors patented by Merck KGaA

ArQule describes lapachone analogues

Aminoalcohol derivatives for the treatment of urinary incontinence

AstraZeneca describes glucokinase activators

First clinical evidence of antitumor effects induced by taurolidine in glioblastoma

Potential of novel anxiolytic LY-544344

Antidepressant and anxiolytic properties of agomelatine

Anxiolytic effects of NK1 and CRF1 receptor antagonists in marmosets

Cellular process in cognition enhancement improved by 5-HT6 receptor antagonists

Antiviral nucleoside derivatives for the treatment of hepatitis C

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...